<DOC>
	<DOCNO>NCT00867477</DOCNO>
	<brief_summary>The goal clinical research study use new breathe test measure amount nitric oxide ( NO ) exhale . Researchers want compare `` NO '' level amount inflammation lung , measure use positron emission tomography ( PET ) scan reading , respiratory symptom questionnaire .</brief_summary>
	<brief_title>PMRR-NO : Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide</brief_title>
	<detailed_description>Lung Cancer Cohort : NO Breathing Test : If agree take part study , breathe test perform start radiation therapy , weekly radiation therapy , 6 week end radiation therapy day restaging PET scan . The breathing test measure much NO exhale breathing . To complete test , exhale device call `` NO breath analyzer '' 10 second . You repeat test 3 time . The result test give researcher information possible inflammation lung . The result test compare result PET scan . For first exhale NO test session , session produce high enough NO level , NO breath test repeat 4 time . The staff ask exhale different speed repeat session , order learn lungs NO come . Respiratory Symptoms Questionnaire : At visit NO breathing test , ask complete questionnaire breathing symptom may . A research assistant able help complete questionnaire . It take 10 minute complete questionnaire . PET scan : After complete radiation therapy , receive PET scan part study . The PET scan schedule 40 50 day end radiation therapy . A study staff member call PET scan date . Ten ( 10 ) participant receive second PET scan within 2-7 day first PET scan order check reproducibility . For 6 hour PET scan , must eat drink anything except water . A small tube place arm , receive injection small amount mildly radioactive sugar material bloodstream . The radioactive nature inject material allow scanner `` see '' certain place body . After injection , need rest quietly time scan . The amount rest time may vary , prepared wait 45 90 minute . During scan , lie flat back table . The scan may last 1 hour . Length Study : You remain study 7 month . After complete breathing test , blood draw , questionnaire , PET scan , participation study . This investigational study . The device ( call NO breath analyzer ) use study FDA approve commercially available measure exhale NO level patient asthma . The use PET scan blood test check lung inflammation also investigational . Up 150 patient ( 47 lung cancer ) take part study . All enrol MD Anderson . Esophageal Cancer Cohort : NO Breathing Test : If agree take part study , breathe test perform start radiation therapy , 5 week later radiation therapy complete ( end radiation therapy ) , day restaging PET scan . The breathing test measure much NO exhale breathing . To complete test , exhale device call `` NO breath analyzer '' 10 second . You repeat test 3 time . The result test give researcher information possible inflammation lung . The result test compare result PET scan . For first exhale NO test session , session produce high enough NO level , NO breath test repeat 4 time . The staff ask exhale different speed repeat session , order learn lungs NO come . Respiratory Symptoms Questionnaire : At visit 3 NO breathing test , ask complete questionnaire breathing symptom may . A research assistant able help complete questionnaire . It take 10 minute complete questionnaire . Length Study : After complete breathing test questionnaire , participation study . This investigational study . The device ( call NO breath analyzer ) use study FDA approve commercially available measure exhale NO level patient asthma . Its use patient esophageal cancer investigational . The optional SPECT scan use 99m Tc-HMPAO FDA approve standard image method infection and/or inflammation . Up 150 patient ( 93 esophageal cancer ) take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Patients pathologic diagnosis esophagus cancer . 2 . For cohort 2 , patient pathological diagnosis lung cancer . 3 . For cohort 3 , patient pathological diagnosis thoracic malignancy . 4 . Patients must sign informed consent . 5 . Patients receive concurrent chemotherapy radiation therapy undergoing PETscan restaging 25 75 day radio therapy . 6 . For Lung Cohort , patient receive concurrent chemotherapy radiation therapy great equal 3 week radiation therapy alone . 7 . For Lung Cohort , participation PETscan restaging 4050 day radiotherapy require . 10 patient receive second PETscan within 27 day test reproducibility . 1 . Significant pleural effusion evaluate attend Radiation Oncologist exclude . 2 . Patients receive thoracic radiotherapy prior study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Cancer esophagus</keyword>
	<keyword>Gastrointestine</keyword>
	<keyword>esophagus cancer</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>PET scan</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>NO</keyword>
	<keyword>NO Breathing Test</keyword>
	<keyword>Respiratory symptom questionnaire</keyword>
</DOC>